Disclosures for "Clinical Decision Support Tool Integrating Dual-Task Gait Biomarkers Predicts Cognitive Decline Progression in Alzheimer's Disease and Mild Cognitive Impairment: A 6-Month Pilot Study."
-
Miss Doshi has nothing to disclose.
-
Dr. Novin has received personal compensation for serving as an employee of RNP. Dr. Novin has received intellectual property interests from a discovery or technology relating to health care. Dr. Novin has received intellectual property interests from a discovery or technology relating to health care. Dr. Novin has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Patel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for RNP MEDICAL .